Croissance Limited has notified BSE Limited of an upcoming Board of Directors meeting, scheduled for Friday, May 8, 2026, at 5:00 PM at the company's registered office located at 306, 1st Floor, 17th Cross, 2nd Block, RT Nagar, Bengaluru 560032, Karnataka. The intimation was filed on May 7, 2026, in compliance with Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The board meeting has been convened to address the following key items:

• Audited Financial Results for the Quarter and Financial Year ended March 31, 2026
• Any other business with the permission of the Chair

The following table summarizes the key details of the scheduled board meeting:

Trading Window Closure

In connection with the upcoming declaration of financial results, Croissance Limited has confirmed that the trading window for dealing in the company's securities by designated persons, their immediate relatives, and all connected persons covered under the Company's Code of Conduct remains closed from April 1, 2026. The trading window will continue to remain closed until 48 hours after the declaration of the results, in line with applicable insider trading regulations.

The intimation was signed by Sravan Prabhakar Veledandi, Managing Director (DIN: 02757599), on behalf of Croissance Limited.

Croissance Limited has announced its Q3FY26 financial results, demonstrating a remarkable turnaround from losses to profitability. The company reported a net profit of ₹1.87 lakhs for the quarter ended December 31, 2025, marking a significant improvement from the loss of ₹27.18 lakhs recorded in the corresponding quarter of the previous year.

Financial Performance Overview

The company's quarterly performance shows substantial improvement across key metrics:

Nine-Month Performance Analysis

The nine-month period ended December 31, 2025, reflects the company's sustained recovery trajectory:

Expense Management

The company demonstrated effective cost control during Q3FY26. Employee benefit expenses increased to ₹12.00 lakhs from ₹9.28 lakhs in the previous year quarter, while other expenses decreased significantly to ₹5.34 lakhs from ₹11.02 lakhs. Finance costs remained minimal at ₹0.05 lakhs, and the company reported no depreciation or exceptional items during the quarter.

Corporate Governance

The Board of Directors meeting was held on January 6, 2026, at 4:00 PM at the company's registered office, concluding at 8:45 PM. The board approved both standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2025. The results were prepared in accordance with Indian Accounting Standards (Ind AS) and SEBI regulations.

Earnings Per Share

With a paid-up equity share capital of ₹685.48 lakhs, the company reported basic and diluted earnings per share of ₹0.00 for Q3FY26, compared to ₹-0.04 in the corresponding previous quarter. For the nine-month period, earnings per share improved to ₹0.01 from ₹-0.06 in the previous year.

Auditor's Review

YCRJ & Associates, Chartered Accountants, conducted a limited review of the financial results. The auditors confirmed that nothing came to their attention suggesting the financial statements contained material misstatements or failed to comply with applicable disclosure requirements under SEBI regulations.